Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01786369 · ClinicalTrials.gov registry record
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 106
- Enrollment target
NCT01786369 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 106 participants.
The verdict
NCT01786369 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
This is a screening study aimed at estimating the frequency of antipsychotic non-compliance in patients with a history of schizophrenia or other psychotic disorder admitted to an inpatient psychiatric unit. Levels of the antipsychotics risperidone, olanzapine, quetiapine, aripiprazole, and paliperidone will be drawn in patients presenting the emergency room who are acutely psychotic, require admission to an inpatient hospital, have a history of psychosis, and have previously been prescribed one of the study drugs. Levels will then be analyzed to determine the frequency and severity of non-compliance in this population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2013-02 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01786369
The ClinicalTrials.gov registry entry for NCT01786369 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01786369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01786369 about?
NCT01786369 is a clinical study titled "Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.". This is a screening study aimed at estimating the frequency of antipsychotic non-compliance in patients with a history of schizophrenia or other psychotic disorder admitted to an inpatient psychiatric unit. Levels of the antipsychotics risperidone, olanzapine, quetiapine, aripiprazole, and paliperid...
What is the current status of trial NCT01786369?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2013-02. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01786369?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.